Navigation Links
International Isotopes Inc. Announces a Shareholder Conference Call for February 7, 2011
Date:1/31/2011

IDAHO FALLS, Idaho, Jan. 31, 2011 /PRNewswire/ -- International Isotopes Inc. (OTC Bulletin Board: INIS), a leading manufacturer of nuclear medicine products, announces a conference call to discuss progress during the fourth quarter of 2010 on the Company's planned uranium de-conversion and fluorine extraction processing facility.

What: International Isotopes Inc. Depleted Uranium Project Update Conference CallWhen: Monday, February 7, 2011 - 10:00AM Central TimeHow:  Live via phone by dialing 800-624-7038. Code: INIS Uranium Project. Participants to the conference call should call in at least 5 minutes prior to the start time. For those who can not attend the call, an audio replay be archived on the Company's web site www.intisoid.com on Tuesday, February 8, 2011.This announcement follows the December 15, 2010 news release of the Company regarding the formation of a new joint venture business with RadQual LLC, and acquisition of the assets of Technology Imaging Services Inc.

Steve T. Laflin, President and CEO will lead the call to discuss the Company's progress on its planned depleted uranium processing and fluorine extraction processing facility during the fourth quarter of 2010 and outline some of the significant milestones the Company plans to accomplish on this project during 2011.

About International Isotopes Inc.International Isotopes Inc. manufactures a full range of nuclear medicine calibration and reference standards, high purity fluoride gases, and a variety of cobalt-60 products such as teletherapy sources.  The Company also provides a wide selection of radioisotopes and radiochemicals for medical devices, calibration, clinical research, life sciences, and industrial applications and provides a host of analytical, measurement, recycling, and processing services on a contract basis to clients. The Company is in the licensing and design phase of its planned environmentally friendly, green technology, uranium de-conversion and fluorine extraction processing facility located near Hobbs, New Mexico.

International Isotopes Inc. Safe Harbor Statement

Certain statements in this press release are "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, including statements with respect to its planned depleted uranium processing and fluorine extraction facility.  Information contained in such forward-looking statements is based on current expectations and is subject to change.  These statements involve a number of risks, uncertainties, and other factors that could cause actual results, performance or achievements of International Isotopes, Inc. to be materially different from any future results, performance or achievements expressed or implied by these forward-looking statements.  Other factors, which could materially affect such forward-looking statements, can be found in International Isotopes, Inc.'s filings with the Securities and Exchange Commission at www.sec.gov, including our annual report on Form 10-K for the year ending December 31, 2009.  Investors, potential investors and other readers are urged to consider these factors carefully in evaluating the forward-looking statements and are cautioned not to place undue reliance on such forward-looking statements.  The forward-looking statements made herein are only made as of the date of this press release and International Isotopes, Inc. undertakes no obligation to publicly update such forward-looking statements to reflect subsequent events or circumstances.FOR MORE INFORMATION CONTACT:Jim DrewitzCreative Options CommunicationsInvestor and Public Relationsjim@jdcreativeoptions.comPhone:  830-669-2466For more information, please visit the Company web site:  www.intisoid.com


'/>"/>

SOURCE International Isotopes Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Bacterin International Holdings Secures $5,000,000 Credit Facility with Bridge Bank
2. 4th International Conference on Electrophoretic Deposition
3. Verenium Announces Favorable Outcome of Capital Ventures International Lawsuit
4. Cellular Dynamics International to Present at 29th Annual JPMorgan Healthcare Conference
5. Halt Medical Presents Strong Results of International Fibroid Studies at National Institutes of Health Global Congress
6. Web of international collaboration boosts worldwide nanotechnology research
7. ViroPharma Incorporated and Idis Partner to Facilitate International Access to Certain ViroPharma Therapeutics Through Named Patient Program
8. Egon Zehnder International Names Todd Hutchings to Lead Life Sciences Practice Group
9. Nu Skin Scientists Present ageLOC Research at International Conference on Mitochondria
10. Medizone International Secures $10,000,000 Funding Commitment
11. PRA International Expert to Speak at China Drug Safety Summit
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/12/2017)... ... October 12, 2017 , ... AMRI, ... and biotechnology industries to improve patient outcomes and quality of life, will now ... testing are being attributed to new regulatory requirements for all new drug products, ...
(Date:10/11/2017)... , ... October 11, 2017 , ... ... gene in its endogenous context, enabling overexpression experiments and avoiding the use of ... small RNA guides is transformative for performing systematic gain-of-function studies. , This ...
(Date:10/11/2017)... ... October 11, 2017 , ... ... today it will be hosting a Webinar titled, “Pathology is going digital. Is ... , on digital pathology adoption best practices and how Proscia improves lab economics ...
(Date:10/11/2017)... ... October 11, 2017 , ... Disappearing forests and increased ... of over 5.5 million people each year. Especially those living in larger cities are ... - based in one of the most pollution-affected countries globally - decided to take ...
Breaking Biology Technology:
(Date:4/11/2017)... PALM BEACH GARDENS, Fla. , April 11, ... biometric identity management and secure authentication solutions, today ... million contract by Intelligence Advanced Research Projects Activity ... technologies for IARPA,s Thor program. "Innovation ... the onset and IARPA,s Thor program will allow ...
(Date:4/11/2017)... 2017 NXT-ID, Inc. (NASDAQ:   NXTD ... the appointment of independent Directors Mr. Robin D. Richards ... of Directors, furthering the company,s corporate governance and expertise. ... Gino Pereira , Chief ... to their guidance and benefiting from their considerable expertise as ...
(Date:4/5/2017)... -- Today HYPR Corp. , leading innovator in ... the HYPR platform is officially FIDO® Certified . ... that empowers biometric authentication across Fortune 500 enterprises and ... 15 million users across the financial services industry, however ... suites and physical access represent a growing portion of ...
Breaking Biology News(10 mins):